search
Back to results

SGA for TEE: Safe Alternative to Deep Sedation for Patients With High-risk Cardiopulmonary Disease. (SGA-TEE)

Primary Purpose

Cardiopulmonary Disease

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TEE with SGA
TEE with Deep Sedation
Sponsored by
University of Florida
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiopulmonary Disease focused on measuring TEE, SGA, Anesthesia, sedation, Chronic Hypoxemic lung Disease, Obstructive Sleep Apnea, Morbid Obesity

Eligibility Criteria

18 Years - 120 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Adults presenting for elective outpatient TEE examinations at UF Shands hospital during the study duration

Exclusion Criteria:

  • Known or suspected difficult airway, patient refusal or inability to consent, patients to have emergent or urgent TEE exams, patients considered to have full stomach ie gastroparesis or achalasia

Sites / Locations

  • UF Health Jacksonville

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control Group

Experimental Group

Arm Description

Deep sedation with propofol and natural airway

SGA Placement and maintenance with inhalational anesthetic or propofol

Outcomes

Primary Outcome Measures

The number of successfully completed TEE examinations with the assigned airway intervention
The primary outcome is a binary data point (yes/no) defined as the success of using the assigned LMA or natural airway successfully for a TEE procedure.

Secondary Outcome Measures

Ease of Placement of LMA
Defined by placement of LMA on first attempt, with good chest rise on positive pressure assisted ventilation, no audible leak on assisted ventilation with cuff pressure <32 cm H2O, and sustained, square waveform capnography
Alternative Airway device
this secondary outcome is a binary data point (yes/no) on the use of an endotracheal tube for rescue from failure of assigned airway type for the procedure (LMA vs natural airway with sedation)
Dislocation of LMA
this secondary outcome is a binary data point (yes/no) for any form of dislocation of the LMA during the endoscopic procedure necessitating repositioning of the LMA.
Chin Lift or Jaw Thrust
this secondary outcome is a binary data point (yes/no) for the need to perform chin lift or jaw thrust to maintain a patent airway.
Pharyngeal Bleeding
the incidence of pharyngeal bleeding during placement or after the procedure
Hypoxia
Hypoxia during the procedure will be defined as an oxygen saturation (SpO2) <92% for more than 5 minutes. Regurgitation defined by visualized gastric contents requiring suctioning Aspiration defined by desaturation after regurgitation with suspicion of the anesthesiologist or CRNA that aspiration occurred.
Aspiration
Aspiration will be defined by desaturation (SpO2 <92) after regurgitation and inhalation of the gastric contents.
Duration of the endoscopic procedure
Insertion to removal of TEE probe
Sore throat
As described on a numerical rating scale, and at time 0, 2, and 24 hours 0= no sore throat , 1= mild sore throat, 2= moderate sore throat, 3= severe sore throat
Ease and comfort of advancing and operating the Endoscope by attending endoscopist
The comfort of advancing and operating the endoscope rated by the attending endoscopist after the procedure via a 5 point Likert-type scale (0 = not at all satisfied, 1=slightly satisfied, 2=moderately satisfied, 3=very satisfied, 4 = completely satisfied).

Full Information

First Posted
May 24, 2021
Last Updated
June 7, 2023
Sponsor
University of Florida
search

1. Study Identification

Unique Protocol Identification Number
NCT04939220
Brief Title
SGA for TEE: Safe Alternative to Deep Sedation for Patients With High-risk Cardiopulmonary Disease.
Acronym
SGA-TEE
Official Title
Supraglottic Airway Use for Transesophageal Echocardiography: a Safe Alternative to Deep Sedation for Patients With High-risk Cardiopulmonary Disease. (SGA-TEE)
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 2023 (Anticipated)
Primary Completion Date
March 9, 2024 (Anticipated)
Study Completion Date
March 9, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Florida

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Increasingly, transesophageal echos (TEEs) are being done on high risk patients. A TEE is a short procedure done with deep sedation, but poses an increased risk of apnea/ hypoxemia in those with pulmonary disease. It is desirable to avoid intubation, which adds risk. Use of supraglottic airway (SGA) may offer an alternative. The investigators hypothesize that TEEs can be done successfully with an SGA in place. The investigators propose a prospective RCT to compare TEE exams done with deep sedation to those done with an SGA.
Detailed Description
Increasingly, non-operating room anesthesia (NORA) cases are being performed on patients with high risk for needing advanced airway management, ie patients with morbid obesity, chronic hypoxemic lung disease, obstructive sleep apnea. Transesophageal echocardiography (TEE) exams are one example of this. While a TEE is typically a short, diagnostic procedure done with deep sedation, deep sedation poses an increased risk of hypoventilation and hypoxemia in patients with cardiopulmonary disease. It is desirable to avoid endotracheal intubation for TEE exams, as the procedure is short and can easily be done without muscle relaxation. Moreover, securing the airway with an endotracheal tube (ETT) is not without significant risk. The use of a supraglottic airway (SGA) may offer an alternative for patients receiving a TEE who are high risk candidates for deep sedation with a natural airway. The investigators hypothesize that the TEE procedure can be done successfully, without interruption, with an SGA in place. Our secondary hypothesis is that SGA use in high-risk patients may be safer than deep sedation, as there may be less episodes of hypoventilation and hypoxemia. The investigators propose a prospective randomized control trial to compare TEE exams done with deep sedation (control group) to those done with SGA (intervention group). Our primary outcome will be TEE study completion, and secondary outcomes will focus on the safety profile of the two groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiopulmonary Disease
Keywords
TEE, SGA, Anesthesia, sedation, Chronic Hypoxemic lung Disease, Obstructive Sleep Apnea, Morbid Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective, randomized control trial
Masking
Participant
Masking Description
Randomization to control group- deep sedation with propofol and natural airway or Experimental group-SGA Placement and maintenance with inhalational anesthetic or propofol.
Allocation
Randomized
Enrollment
110 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
Deep sedation with propofol and natural airway
Arm Title
Experimental Group
Arm Type
Experimental
Arm Description
SGA Placement and maintenance with inhalational anesthetic or propofol
Intervention Type
Procedure
Intervention Name(s)
TEE with SGA
Intervention Description
SGA Placement and maintenance with inhalational anesthetic or propofol
Intervention Type
Procedure
Intervention Name(s)
TEE with Deep Sedation
Intervention Description
Deep sedation with propofol and natural airway
Primary Outcome Measure Information:
Title
The number of successfully completed TEE examinations with the assigned airway intervention
Description
The primary outcome is a binary data point (yes/no) defined as the success of using the assigned LMA or natural airway successfully for a TEE procedure.
Time Frame
Duration of procedure
Secondary Outcome Measure Information:
Title
Ease of Placement of LMA
Description
Defined by placement of LMA on first attempt, with good chest rise on positive pressure assisted ventilation, no audible leak on assisted ventilation with cuff pressure <32 cm H2O, and sustained, square waveform capnography
Time Frame
Duration of procedure
Title
Alternative Airway device
Description
this secondary outcome is a binary data point (yes/no) on the use of an endotracheal tube for rescue from failure of assigned airway type for the procedure (LMA vs natural airway with sedation)
Time Frame
Duration of procedure
Title
Dislocation of LMA
Description
this secondary outcome is a binary data point (yes/no) for any form of dislocation of the LMA during the endoscopic procedure necessitating repositioning of the LMA.
Time Frame
Duration of procedure
Title
Chin Lift or Jaw Thrust
Description
this secondary outcome is a binary data point (yes/no) for the need to perform chin lift or jaw thrust to maintain a patent airway.
Time Frame
Duration of Procedure
Title
Pharyngeal Bleeding
Description
the incidence of pharyngeal bleeding during placement or after the procedure
Time Frame
Duration of Procedure
Title
Hypoxia
Description
Hypoxia during the procedure will be defined as an oxygen saturation (SpO2) <92% for more than 5 minutes. Regurgitation defined by visualized gastric contents requiring suctioning Aspiration defined by desaturation after regurgitation with suspicion of the anesthesiologist or CRNA that aspiration occurred.
Time Frame
Duration of Procedure
Title
Aspiration
Description
Aspiration will be defined by desaturation (SpO2 <92) after regurgitation and inhalation of the gastric contents.
Time Frame
Duration of Procedure
Title
Duration of the endoscopic procedure
Description
Insertion to removal of TEE probe
Time Frame
Duration of Procedure
Title
Sore throat
Description
As described on a numerical rating scale, and at time 0, 2, and 24 hours 0= no sore throat , 1= mild sore throat, 2= moderate sore throat, 3= severe sore throat
Time Frame
Duration of procedure up to 24 hours after the procedure ends.
Title
Ease and comfort of advancing and operating the Endoscope by attending endoscopist
Description
The comfort of advancing and operating the endoscope rated by the attending endoscopist after the procedure via a 5 point Likert-type scale (0 = not at all satisfied, 1=slightly satisfied, 2=moderately satisfied, 3=very satisfied, 4 = completely satisfied).
Time Frame
Duration of procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
120 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adults presenting for elective outpatient TEE examinations at UF Shands hospital during the study duration Exclusion Criteria: Known or suspected difficult airway, patient refusal or inability to consent, patients to have emergent or urgent TEE exams, patients considered to have full stomach ie gastroparesis or achalasia
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Stefan Braunecker, MD, PhD
Phone
904-244-5431
Email
stefan.braunecker@jax.ufl.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Kelly N Flynn, MS
Phone
904-244-4378
Email
kelly.flynn@jax.ufl.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stefan Braunecker, MD, PhD
Organizational Affiliation
University of Florida
Official's Role
Principal Investigator
Facility Information:
Facility Name
UF Health Jacksonville
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32209
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Paul D Mongan, MD
First Name & Middle Initial & Last Name & Degree
Kerri Lydon, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31257818
Citation
Chiew WA, Chen Q, Tan LZ. Use of LMAⓇ GastroTM in esophagogastroduodenoscopy and endoscopy. Korean J Anesthesiol. 2019 Dec;72(6):618-619. doi: 10.4097/kja.19163. Epub 2019 Jul 1. No abstract available.
Results Reference
background
PubMed Identifier
29406183
Citation
Terblanche NCS, Middleton C, Choi-Lundberg DL, Skinner M. Efficacy of a new dual channel laryngeal mask airway, the LMA(R)Gastro Airway, for upper gastrointestinal endoscopy: a prospective observational study. Br J Anaesth. 2018 Feb;120(2):353-360. doi: 10.1016/j.bja.2017.11.075. Epub 2017 Dec 1.
Results Reference
background
PubMed Identifier
32404136
Citation
Tran A, Thiruvenkatarajan V, Wahba M, Currie J, Rajbhoj A, van Wijk R, Teo E, Lorenzetti M, Ludbrook G. LMA(R) Gastro Airway for endoscopic retrograde cholangiopancreatography: a retrospective observational analysis. BMC Anesthesiol. 2020 May 13;20(1):113. doi: 10.1186/s12871-020-01019-5.
Results Reference
background
PubMed Identifier
32035477
Citation
Schmutz A, Loeffler T, Schmidt A, Goebel U. LMA Gastro airway is feasible during upper gastrointestinal interventional endoscopic procedures in high risk patients: a single-center observational study. BMC Anesthesiol. 2020 Feb 8;20(1):40. doi: 10.1186/s12871-020-0938-9.
Results Reference
background
PubMed Identifier
33061677
Citation
Hakim M, Bryant J, Miketic R, Williams K, Erdman SH, Shafy SZ, Kim SS, Tobias JD. Clinical Outcomes of a Modified Laryngeal Mask Airway (LMA(R) Gastro Airway) During Esophagogastroduodenoscopy in Children and Adolescents: A Randomized Study. Med Devices (Auckl). 2020 Sep 21;13:277-282. doi: 10.2147/MDER.S272557. eCollection 2020.
Results Reference
background
PubMed Identifier
31149001
Citation
Waruingi D, Mung'ayi V, Gisore E, Wanyonyi S. A randomised controlled trial of the effect of laryngeal mask airway manometry on postoperative sore throat in spontaneously breathing adult patients presenting for surgery at a university teaching hospital. Afr Health Sci. 2019 Mar;19(1):1705-1715. doi: 10.4314/ahs.v19i1.47.
Results Reference
background
PubMed Identifier
20179502
Citation
Seet E, Yousaf F, Gupta S, Subramanyam R, Wong DT, Chung F. Use of manometry for laryngeal mask airway reduces postoperative pharyngolaryngeal adverse events: a prospective, randomized trial. Anesthesiology. 2010 Mar;112(3):652-7. doi: 10.1097/ALN.0b013e3181cf4346.
Results Reference
background
PubMed Identifier
29229253
Citation
Balmforth D, Smith A, Nagore D, Schilling R, O'Brien B. Can Transesophageal Echocardiography Be Performed Safely Using a Laryngeal Mask Airway During Atrial Fibrillation Ablation? J Cardiothorac Vasc Anesth. 2018 Apr;32(2):790-795. doi: 10.1053/j.jvca.2017.10.040. Epub 2017 Nov 2.
Results Reference
background
PubMed Identifier
10589667
Citation
Salvi L, Pepi M. Pressure-assisted breathing through a laryngeal mask airway during transesophageal echocardiography. Anesth Analg. 1999 Dec;89(6):1591-2. doi: 10.1097/00000539-199912000-00070. No abstract available.
Results Reference
background
PubMed Identifier
12968230
Citation
Ferson D, Thakar D, Swafford J, Sinha A, Sapire K, Arens J. Use of deep intravenous sedation with propofol and the laryngeal mask airway during transesophageal echocardiography. J Cardiothorac Vasc Anesth. 2003 Aug;17(4):443-6. doi: 10.1016/s1053-0770(03)00147-2.
Results Reference
background
PubMed Identifier
30734949
Citation
Patrick Mayr N, Michel J, Wiesner G, Rumpf PM. Supraglottic airway device use for transoesophageal echocardiography during left atrial appendage occlusion. Anaesthesia. 2019 Mar;74(3):405-406. doi: 10.1111/anae.14597. No abstract available.
Results Reference
background
PubMed Identifier
31101507
Citation
Saxena S, Aminian A, Nahrwold DA, Daper A. LMA Gastro Airway Seen Through the Eyes of a Cardiac Anesthesiologist. J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2365-2366. doi: 10.1053/j.jvca.2019.04.014. Epub 2019 Apr 20. No abstract available.
Results Reference
background
Links:
URL
https://www.sealedenvelope.com/power/binary-noninferior/
Description
Power calculator for binary outcome non-inferiority trial. Sealed Envelope Ltd. 2012. Power calculator for binary outcome non-inferiority trial. [Online] [Accessed Sat Apr 03 2021].

Learn more about this trial

SGA for TEE: Safe Alternative to Deep Sedation for Patients With High-risk Cardiopulmonary Disease.

We'll reach out to this number within 24 hrs